CD8A and listeriosis: We conclude that DC-GAPDH1−22, which combines several CD4+ and CD8+ epitopes in a single vaccine vector, shows greater protection against listeriosis, because this DC vaccine increases the magnitude of primary T cell responses, the percentage of GAPDH1−22-restricted CD8+ T cells, and the levels of IL-12.